BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1548130)

  • 21. [The effect of selenium on enzymes metabolizing xenobiotics in rat liver].
    Kravchenko LV; Kuz'mina EE; Avren'eva LI; Pozdniakov AL
    Vopr Med Khim; 1991; 37(5):73-6. PubMed ID: 1759407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of drug metabolizing enzymes in the effect and side-effect of the drugs].
    Vereczkey L; Jemnitz K; Monostory K; Veres Z; Kóbori L
    Orv Hetil; 2005 May; 146(19):947-52. PubMed ID: 15969306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of ultimate mutagenic species by diverse enzymes.
    Oesch F; Doehmer J; Friedberg T; Glatt H; Oesch-Bartlomowicz B; Platt KL; Steinberg P; Utesch D; Thomas H
    Prog Clin Biol Res; 1990; 340B():49-65. PubMed ID: 2168050
    [No Abstract]   [Full Text] [Related]  

  • 24. Adaptive responses of the liver to foreign compounds, with special reference to microsomal drug-matabolizing enzymes.
    Wada O; Yano Y
    Rev Environ Health; 1974; 1(4):261-82. PubMed ID: 4617260
    [No Abstract]   [Full Text] [Related]  

  • 25. Genetic polymorphisms in drug-metabolizing enzymes and drug targets.
    Hiratsuka M; Mizugaki M
    Mol Genet Metab; 2001 Aug; 73(4):298-305. PubMed ID: 11509011
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug-metabolizing enzymes in the skin of man, rat, and pig.
    Oesch F; Fabian E; Oesch-Bartlomowicz B; Werner C; Landsiedel R
    Drug Metab Rev; 2007; 39(4):659-98. PubMed ID: 18058329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Does the cytochrome P-450-dependent system of microsomal monooxygenases protect the body from the toxic effect of xenobiotics?].
    Lutz W; Szeszko A; Stankiewicz A
    Pol Tyg Lek; 1988 Jun; 43(25):795-8. PubMed ID: 3149404
    [No Abstract]   [Full Text] [Related]  

  • 28. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of xenobiotic-metabolizing enzymes in liver and intestine of various animal species.
    Chhabra RS; Pohl RJ; Fouts JR
    Drug Metab Dispos; 1974; 2(5):443-7. PubMed ID: 4156307
    [No Abstract]   [Full Text] [Related]  

  • 30. [Human drug metabolizing enzymes. I. Oxidative enzymes].
    Vereczkey L; Monostory K; Veres Z
    Acta Pharm Hung; 1998 Sep; 68(5):276-83. PubMed ID: 9805813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biotransformation of drugs in human skin.
    Svensson CK
    Drug Metab Dispos; 2009 Feb; 37(2):247-53. PubMed ID: 19005027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in inducibility of cutaneous and hepatic drug metabolizing enzymes and cytochrome P-450 by polychlorinated biphenyls and 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT).
    Bickers DR; Kappas A; Alvares AP
    J Pharmacol Exp Ther; 1974 Feb; 188(2):300-9. PubMed ID: 4204348
    [No Abstract]   [Full Text] [Related]  

  • 33. [Human drug metabolizing enzymes. II. Conjugation enzymes].
    Vereczkey L; Jemnitz K; Gregus Z
    Acta Pharm Hung; 1998 Sep; 68(5):284-8. PubMed ID: 9805814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Human drug metabolizing enzymes III. Epoxide hydrolases, esterases, and amidases].
    Hazai E; Róna K; Vereczkey L
    Acta Pharm Hung; 1999 Sep; 69(4):208-12. PubMed ID: 10544521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug metabolism in in vitro organotypic and cellular models of mammalian central nervous system: activities of membrane-bound epoxide hydrolase and NADPH-cytochrome P-450 (c) reductase.
    Teissier E; Fennrich S; Strazielle N; Daval JL; Ray D; Schlosshauer B; Ghersi-Egea JF
    Neurotoxicology; 1998 Jun; 19(3):347-55. PubMed ID: 9621341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of induction of cytochrome P-450 enzymes on the concentration of foreign compounds and their metabolites and on the toxicological effects of these compounds.
    Gillette JR
    Drug Metab Rev; 1979; 10(1):59-87. PubMed ID: 118860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Xenobiotic-metabolizing enzymes in human lung.
    Zhang JY; Wang Y; Prakash C
    Curr Drug Metab; 2006 Dec; 7(8):939-48. PubMed ID: 17168693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the drug-metabolizing enzymes.
    Bridges JW
    Ciba Found Symp; 1980; 76():5-24. PubMed ID: 6780281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug skin metabolites and allergic drug reactions.
    Merk HF
    Curr Opin Allergy Clin Immunol; 2009 Aug; 9(4):311-5. PubMed ID: 19535973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of drug-metabolizing enzymes: mechanisms and consequences.
    Okey AB; Roberts EA; Harper PA; Denison MS
    Clin Biochem; 1986 Apr; 19(2):132-41. PubMed ID: 3518989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.